COVID-19's impact to Global Targeted Drugs for NSCLC Market Research Report 2020, Forecast to 2025
SKU ID : MMI-16401336 | Publishing Date : 09-Sep-2020 | No. of pages : 161
Detailed TOC of COVID-19's impact to Global Targeted Drugs for NSCLC Market Research Report 2020, Forecast to 2025
Table of ContentsGlobal Targeted Drugs for NSCLC Market Research Report 2020, Forecast to 2025
1 Market Overview
1.1 Targeted Drugs for NSCLC Definition
1.1.1 Analysis of Macroeconomic Indicators
1.1.2 Years Considered
1.2 Targeted Drugs for NSCLC Segment by Type
1.2.1 Bevacizumab
1.2.2 Sorafenib
1.2.3 Ramucirumab
1.2.4 Sunitinib
1.2.5 Apatinib
1.3 Market Analysis by Application
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Overview of Global Targeted Drugs for NSCLC Market
1.4.1 Global Targeted Drugs for NSCLC Revenue (2015-2025)
1.4.2 Global Targeted Drugs for NSCLC Production and Capacity (2015-2025)
1.4.3 North America Targeted Drugs for NSCLC Status and Prospect (2015-2025)
1.4.4 Europe Targeted Drugs for NSCLC Status and Prospect (2015-2025)
1.4.5 Japan Targeted Drugs for NSCLC Status and Prospect (2014-2025)
1.4.6 China Targeted Drugs for NSCLC Status and Prospect (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.5.4 Porter's Five Forces Analysis
1.5.5 SWOT Analysis
1.6 Coronavirus Disease 2019 (Covid-19): Targeted Drugs for NSCLC Industry Impact
1.6.1 How the Covid-19 is Affecting the Targeted Drugs for NSCLC Industry
1.6.2 Targeted Drugs for NSCLC Business Impact Assessment - Covid-19
1.6.3 Market Trends and Targeted Drugs for NSCLC Potential Opportunities in the COVID-19 Landscape
1.6.4 Measures / Proposal against Covid-19
2 Global Targeted Drugs for NSCLC Market Competition by Manufacturer
2.1 Global Targeted Drugs for NSCLC Sales and Market Share by Manufacturer (2018-2020)
2.2 Global Targeted Drugs for NSCLC Revenue and Market Share by Manufacturer (2018-2020)
2.3 Global Targeted Drugs for NSCLC Industry Concentration Ratio (CR5 and HHI)
2.4 Top 5 Targeted Drugs for NSCLC Manufacturer Market Share
2.5 Top 10 Targeted Drugs for NSCLC Manufacturer Market Share
2.6 Date of Key Manufacturers Enter into Targeted Drugs for NSCLC Market
2.7 Key Manufacturers Targeted Drugs for NSCLC Product Offered
2.8 Mergers & Acquisitions Planning
3 Analysis of Targeted Drugs for NSCLC Industry Key Manufacturers
3.1 Genentech
3.1.1 Company Details
3.1.2 Product Information
3.1.3 Genentech Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.1.4 Main Business Overview
3.1.5 Genentech News
3.2 Allergan
3.2.1 Company Details
3.2.2 Product Information
3.2.3 Allergan Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.2.4 Main Business Overview
3.2.5 Allergan News
3.3 Hetero Drugs
3.3.1 Company Details
3.3.2 Product Information
3.3.3 Hetero Drugs Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.3.4 Main Business Overview
3.3.5 Hetero Drugs News
3.4 Reliance Life Science
3.4.1 Company Details
3.4.2 Product Information
3.4.3 Reliance Life Science Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.4.4 Main Business Overview
3.4.5 Reliance Life Science News
3.5 Bayer
3.5.1 Company Details
3.5.2 Product Information
3.5.3 Bayer Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.5.4 Main Business Overview
3.5.5 Bayer News
3.6 Natco Pharma
3.6.1 Company Details
3.6.2 Product Information
3.6.3 Natco Pharma Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.6.4 Main Business Overview
3.6.5 Natco Pharma News
3.7 Cipla
3.7.1 Company Details
3.7.2 Product Information
3.7.3 Cipla Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.7.4 Main Business Overview
3.7.5 Cipla News
3.8 Mylan
3.8.1 Company Details
3.8.2 Product Information
3.8.3 Mylan Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.8.4 Main Business Overview
3.8.5 Mylan News
3.9 Eli Lilly
3.9.1 Company Details
3.9.2 Product Information
3.9.3 Eli Lilly Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.9.4 Main Business Overview
3.9.5 Eli Lilly News
3.10 Pfizer
3.10.1 Company Details
3.10.2 Product Information
3.10.3 Pfizer Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.10.4 Main Business Overview
3.10.5 Pfizer News
3.11 Advenchen Laboratories
3.11.1 Company Details
3.11.2 Product Information
3.11.3 Advenchen Laboratories Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.11.4 Main Business Overview
3.11.5 Advenchen Laboratories News
3.12 Jiangsu Hengrui Medicine
3.12.1 Company Details
3.12.2 Product Information
3.12.3 Jiangsu Hengrui Medicine Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.12.4 Main Business Overview
3.12.5 Jiangsu Hengrui Medicine News
3.13 LSK BioPartners
3.13.1 Company Details
3.13.2 Product Information
3.13.3 LSK BioPartners Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.13.4 Main Business Overview
3.13.5 LSK BioPartners News
3.14 Bukwang Pharmaceutical Company
3.14.1 Company Details
3.14.2 Product Information
3.14.3 Bukwang Pharmaceutical Company Targeted Drugs for NSCLC Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.14.4 Main Business Overview
3.14.5 Bukwang Pharmaceutical Company News
4 Global Targeted Drugs for NSCLC Market Size Categorized by Regions (2015-2020)
4.1 Global Targeted Drugs for NSCLC Sales Market Share by Region
4.2 Global Targeted Drugs for NSCLC Revenue Market Share by Region (2015-2019)
4.3 Global Targeted Drugs for NSCLC Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Targeted Drugs for NSCLC Market Size Detail
4.4.1 North America Targeted Drugs for NSCLC Sales Growth Rate (2015-2020)
4.4.2 North America Targeted Drugs for NSCLC Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Targeted Drugs for NSCLC Market Size Detail
4.5.1 Europe Targeted Drugs for NSCLC Sales Growth Rate (2015-2020)
4.5.2 Europe Targeted Drugs for NSCLC Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Targeted Drugs for NSCLC Market Size Detail
4.6.1 Japan Targeted Drugs for NSCLC Sales Growth Rate (2015-2020)
4.6.2 Japan Targeted Drugs for NSCLC Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Targeted Drugs for NSCLC Market Size Detail
4.7.1 China Targeted Drugs for NSCLC Sales Growth Rate (2015-2020)
4.7.2 China Targeted Drugs for NSCLC Sales, Revenue, Price and Gross Margin (2015-2020)
5 Global Targeted Drugs for NSCLC Market Segment by Type
5.1 Global Targeted Drugs for NSCLC Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Targeted Drugs for NSCLC Sales and Market Share by Type (2015-2020)
5.1.2 Global Targeted Drugs for NSCLC Revenue and Market Share by Type (2015-2020)
5.2 Bevacizumab Sales Growth Rate and Price
5.2.1 Global Bevacizumab Sales Growth Rate (2015-2020)
5.2.2 Global Bevacizumab Price (2015-2020)
5.3 Sorafenib Sales Growth Rate and Price
5.3.1 Global Sorafenib Sales Growth Rate (2015-2020)
5.3.2 Global Sorafenib Price (2015-2020)
5.4 Ramucirumab Sales Growth Rate and Price
5.4.1 Global Ramucirumab Sales Growth Rate (2015-2020)
5.4.2 Global Ramucirumab Price (2015-2020)
5.5 Sunitinib Sales Growth Rate and Price
5.5.1 Global Sunitinib Sales Growth Rate (2015-2020)
5.5.2 Global Sunitinib Price (2015-2020)
5.6 Apatinib Sales Growth Rate and Price
5.6.1 Global Apatinib Sales Growth Rate (2015-2020)
5.6.2 Global Apatinib Price (2015-2020)
6 Global Targeted Drugs for NSCLC Market Segment by Application
6.1 Global Targeted Drugs for NSCLC Sales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Drug Center Sales Growth Rate (2015-2020)
6.5 Other Sales Growth Rate (2015-2020)
7 Targeted Drugs for NSCLC Related Market Analysis
7.1 Upstream Analysis
7.1.1 Macro Analysis of Upstream Markets
7.1.2 Key Players in Upstream Markets
7.1.3 Upstream Market Trend Analysis
7.1.4 Targeted Drugs for NSCLC Manufacturing Cost Analysis
7.2 Downstream Market Analysis
7.2.1 Macro Analysis of Down Markets
7.2.2 Key Players in Down Markets
7.2.3 Downstream Market Trend Analysis
7.2.4 Sales Channel, Distributors, Traders and Dealers
8 Global Targeted Drugs for NSCLC Market Forecast
8.1 Global Targeted Drugs for NSCLC Sales, Revenue Forecast
8.1.1 Global Targeted Drugs for NSCLC Sales Growth Rate Forecast (2020-2025)
8.1.2 Global Targeted Drugs for NSCLC Revenue and Growth Rate Forecast (2020-2025)
8.1.3 Global Targeted Drugs for NSCLC Price and Trend Forecast (2020-2025)
8.2 Global Targeted Drugs for NSCLC Sales Forecast by Region (2020-2025)
8.2.1 North America Targeted Drugs for NSCLC Sales, Revenue Forecast (2020-2025)
8.2.2 Europe Targeted Drugs for NSCLC Sales, Revenue Forecast (2020-2025)
8.2.3 Japan Targeted Drugs for NSCLC Production, Revenue Forecast (2020-2025)
8.2.4 China Targeted Drugs for NSCLC Production, Revenue Forecast (2020-2025)
9 Research Findings and Conclusion
10 Appendix
List of Figures, Tables and Charts Available in COVID-19's impact to Global Targeted Drugs for NSCLC Market Research Report 2020, Forecast to 2025
List of Tables and FiguresFigure Targeted Drugs for NSCLC Picture
Table Global Targeted Drugs for NSCLC Sales by Type
Figure Global Sales Market Share of Targeted Drugs for NSCLC by Product Type in 2019
Table Breakdown of Targeted Drugs for NSCLC by Company Type (Tier 1, Tier 2 and Tier 3)
Figure Targeted Drugs for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure Bevacizumab Picture
Figure Sorafenib Picture
Figure Ramucirumab Picture
Figure Sunitinib Picture
Figure Apatinib Picture
Table Global Targeted Drugs for NSCLC Sales by Application
Figure Global Targeted Drugs for NSCLC Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Targeted Drugs for NSCLC Market Size Comparison by Region (2019-2025) (K Units) & (Million US$)
Figure Global Targeted Drugs for NSCLC Revenue (Million US$) (2015-2025)
Figure Global Targeted Drugs for NSCLC Production (K Units) (2015-2025)
Figure North America Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate (2015-2025)
Figure Europe Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate (2015-2025)
Figure Japan Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate (2014-2025)
Figure China Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate (2015-2025)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table SWOT Analysis
Table Global Targeted Drugs for NSCLC Sales by Manufacturer (2018-2020)
Figure Global Targeted Drugs for NSCLC Sales Market Share by Manufacturer in 2019
Table Global Targeted Drugs for NSCLC Revenue by Manufacturer (2018-2020)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Manufacturer in 2019
Table Global Targeted Drugs for NSCLC Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Targeted Drugs for NSCLC Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Targeted Drugs for NSCLC Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Targeted Drugs for NSCLC Market
Table Key Manufacturers Targeted Drugs for NSCLC Product Type
Table Mergers & Acquisitions Planning
Table Genentech Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Genentech
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genentech Targeted Drugs for NSCLC Market Share (2018-2020)
Table Genentech Main Business
Table Genentech Recent Development
Table Allergan Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Allergan
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Allergan Targeted Drugs for NSCLC Market Share (2018-2020)
Table Allergan Main Business
Table Allergan Recent Development
Table Hetero Drugs Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Hetero Drugs
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Hetero Drugs Targeted Drugs for NSCLC Market Share (2018-2020)
Table Hetero Drugs Main Business
Table Hetero Drugs Recent Development
Table Reliance Life Science Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Reliance Life Science
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Reliance Life Science Targeted Drugs for NSCLC Market Share (2018-2020)
Table Reliance Life Science Main Business
Table Reliance Life Science Recent Development
Table Bayer Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Bayer
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer Targeted Drugs for NSCLC Market Share (2018-2020)
Table Bayer Main Business
Table Bayer Recent Development
Table Natco Pharma Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Natco Pharma
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Natco Pharma Targeted Drugs for NSCLC Market Share (2018-2020)
Table Natco Pharma Main Business
Table Natco Pharma Recent Development
Table Cipla Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Cipla
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cipla Targeted Drugs for NSCLC Market Share (2018-2020)
Table Cipla Main Business
Table Cipla Recent Development
Table Mylan Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Mylan
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mylan Targeted Drugs for NSCLC Market Share (2018-2020)
Table Mylan Main Business
Table Mylan Recent Development
Table Eli Lilly Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Eli Lilly
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly Targeted Drugs for NSCLC Market Share (2018-2020)
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Pfizer Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Pfizer
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Targeted Drugs for NSCLC Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Advenchen Laboratories Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Advenchen Laboratories
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Advenchen Laboratories Targeted Drugs for NSCLC Market Share (2018-2020)
Table Advenchen Laboratories Main Business
Table Advenchen Laboratories Recent Development
Table Jiangsu Hengrui Medicine Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Jiangsu Hengrui Medicine
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Jiangsu Hengrui Medicine Targeted Drugs for NSCLC Market Share (2018-2020)
Table Jiangsu Hengrui Medicine Main Business
Table Jiangsu Hengrui Medicine Recent Development
Table LSK BioPartners Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of LSK BioPartners
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure LSK BioPartners Targeted Drugs for NSCLC Market Share (2018-2020)
Table LSK BioPartners Main Business
Table LSK BioPartners Recent Development
Table Bukwang Pharmaceutical Company Company Profile
Figure Targeted Drugs for NSCLC Product Picture and Specifications of Bukwang Pharmaceutical Company
Table Targeted Drugs for NSCLC Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bukwang Pharmaceutical Company Targeted Drugs for NSCLC Market Share (2018-2020)
Table Bukwang Pharmaceutical Company Main Business
Table Bukwang Pharmaceutical Company Recent Development
Table Global Targeted Drugs for NSCLC Sales (K Units) by Region (2015-2020)
Table Global Targeted Drugs for NSCLC Sales Market Share by Region (2015-2019)
Figure Global Targeted Drugs for NSCLC Sales Market Share by Region (2015-2019)
Figure Global Targeted Drugs for NSCLC Sales Market Share by Region in 2018
Table Global Targeted Drugs for NSCLC Revenue (Million US$) by Region (2015-2020)
Table Global Targeted Drugs for NSCLC Revenue Market Share by Region (2015-2020)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Region (2015-2020)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Region in 2019
Table Global Targeted Drugs for NSCLC Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Targeted Drugs for NSCLC Sales (K Units) Growth Rate (2015-2020)
Figure Europe Targeted Drugs for NSCLC Sales (K Units) Growth Rate (2015-2020)
Table Europe Targeted Drugs for NSCLC Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Targeted Drugs for NSCLC Sales (K Units) Growth Rate (2015-2020)
Table Japan Targeted Drugs for NSCLC Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Targeted Drugs for NSCLC Sales (K Units) Growth Rate (2015-2020)
Table China Targeted Drugs for NSCLC Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Targeted Drugs for NSCLC Sales by Type (2015-2020)
Table Global Targeted Drugs for NSCLC Sales Market Share by Type (2015-2020)
Figure Global Targeted Drugs for NSCLC Sales Market Share by Type in 2019
Table Global Targeted Drugs for NSCLC Revenue by Type (2015-2020)
Table Global Targeted Drugs for NSCLC Revenue Market Share by Type (2015-2020)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Type in 2019
Figure Global Bevacizumab Sales Growth Rate (2015-2025)
Figure Global Bevacizumab Price (2015-2020)
Figure Global Sorafenib Sales Growth Rate (2015-2025)
Figure Global Sorafenib Price (2015-2020)
Figure Global Ramucirumab Sales Growth Rate (2015-2025)
Figure Global Ramucirumab Price (2015-2020)
Figure Global Sunitinib Sales Growth Rate (2015-2025)
Figure Global Sunitinib Price (2015-2020)
Figure Global Apatinib Sales Growth Rate (2015-2025)
Figure Global Apatinib Price (2015-2020)
Table Global Targeted Drugs for NSCLC Sales Market Share by Application (2015-2020)
Figure Global Targeted Drugs for NSCLC Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2025)
Figure Global Clinic Sales Growth Rate (2015-2025)
Figure Global Drug Center Sales Growth Rate (2015-2025)
Figure Global Other Sales Growth Rate (2015-2025)
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Targeted Drugs for NSCLC
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Global Targeted Drugs for NSCLC Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Targeted Drugs for NSCLC Price and Trend Forecast (2020-2025)
Table Global Targeted Drugs for NSCLC Sales (K Units) Forecast by Region (2020-2025)
Figure Global Targeted Drugs for NSCLC Production Market Share Forecast by Region (2020-2025)
Figure North America Targeted Drugs for NSCLC Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Targeted Drugs for NSCLC Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Targeted Drugs for NSCLC Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Targeted Drugs for NSCLC Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Targeted Drugs for NSCLC Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Keyplayers in COVID-19's impact to Global Targeted Drugs for NSCLC Market Research Report 2020, Forecast to 2025
GenentechAllergan
Hetero Drugs
Reliance Life Science
Bayer
Natco Pharma
Cipla
Mylan
Eli Lilly
Pfizer
Advenchen Laboratories
Jiangsu Hengrui Medicine